Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzaknen Regimen for Mild-to-Moderate Acne
NCT02589405Phase 4Completed
- Sponsor
- Galderma
- Start
- Aug 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Number of Participants Satisfied and Very Satisfied With Regimen at 12 weeks. Started Aug 2015; status: completed.
02
Drugs
benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02589405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589405.